CVE-2024-27920

Unsigned code template execution through workflows in projectdiscovery/nuclei

Description

projectdiscovery/nuclei is a fast and customisable vulnerability scanner based on simple YAML based DSL. A significant security oversight was identified in Nuclei v3, involving the execution of unsigned code templates through workflows. This vulnerability specifically affects users utilizing custom workflows, potentially allowing the execution of malicious code on the user's system. This advisory outlines the impacted users, provides details on the security patch, and suggests mitigation strategies. The vulnerability is addressed in Nuclei v3.2.0. Users are strongly recommended to update to this version to mitigate the security risk. Users should refrain from using custom workflows if unable to upgrade immediately. Only trusted, verified workflows should be executed.

Category

7.4
CVSS
Severity: High
CVSS 3.1 •
EPSS 0.03%
Affected: projectdiscovery nuclei
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2024-27920?
CVE-2024-27920 has been scored as a high severity vulnerability.
How to fix CVE-2024-27920?
To fix CVE-2024-27920, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2024-27920 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2024-27920 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2024-27920?
CVE-2024-27920 affects projectdiscovery nuclei.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.